AMLX
AMLX
NASDAQ · Pharmaceuticals

Amylyx Pharmaceuticals Inc

$16.43
+0.06 (+0.37%)
As of Jun 24, 1:46 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 16 89%
Hold 2 11%
Sell 0 0%
Price Target
Analyst Price Target +126.1% upside
Low Target $28.49
Average Target $37.15
High Target $49.81
Current Price $16.43
Current
$16.43
Target
$37.15
$28.49 $37.15 avg $49.81
Scenario Analysis
Bear Case
$28.49
73.4%
Low target
Base Case
$37.15
+126.1%
Avg target
Bull Case
$49.81
+203.2%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$18.61
-11.7% from high
52-Week Low
$4.80
+242.3% from low
Target vs 52W High
$37.15
+99.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.1%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +32.1%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +41.0%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%